Impact of the Advent of Collagenase Clostridium Histolyticum on the Surgical Management of Peyronie’s Disease: A Population-Based Analysis

Penile plication or partial excision with grafting has traditionally been the first-line treatment for stable Peyronie’s disease (PD). Numerous injection therapies (ITs) have been introduced over the last few decades. Intralesional collagenase clostridium histolyticum (CCH) was U.S. Food and Drug Administration approved in 2013 for patients with stable disease, curvature ≥30° and ≤90°, and intact…

Read the full article here

Related Articles